Salarius Pharmaceuticals マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
David Arthur
最高経営責任者
US$544.6k
報酬総額
| CEO給与比率 | 91.8% |
| CEO在任期間 | 5.3yrs |
| CEOの所有権 | 0.4% |
| 経営陣の平均在職期間 | データなし |
| 取締役会の平均在任期間 | 5.3yrs |
経営陣の近況
Recent updates
Salarius pharmaceuticals announces 1-for-25 reverse stock split
Oct 14Salarius adds 12% after updates on clinical programs and financials
Sep 13Salarius Pharma adds two Mayo Clinic sites to phase 1/2 trial of Seclidemstat as treatment for cancers
Aug 22Salarius Pharmaceuticals GAAP EPS of -$0.09 beats by $0.01
Aug 08Salarius Pharmaceuticals and VolitionRx enter into R&D collaboration agreement
Aug 02Salarius Pharma reports new seclidemstat results in Ewing sarcoma and other solid tumors at ASCO21
Jun 07Salarius Pharmaceuticals (SLRX) Investor Presentation - Slideshow
May 27Salarius Pharmaceuticals (NASDAQ:SLRX) Shareholders Have Enjoyed An Impressive 155% Share Price Gain
Feb 09
Salarius Pharmaceuticals receives second installment of $1.7M in payments
Jan 13Salarius Pharma raises $3.5M via warrant exercise
Dec 11Salarius Pharmaceuticals EPS in-line, beats on revenue
Nov 11CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$5m |
| Jun 30 2024 | n/a | n/a | -US$6m |
| Mar 31 2024 | n/a | n/a | -US$9m |
| Dec 31 2023 | US$545k | US$500k | -US$13m |
| Sep 30 2023 | n/a | n/a | -US$18m |
| Jun 30 2023 | n/a | n/a | -US$30m |
| Mar 31 2023 | n/a | n/a | -US$31m |
| Dec 31 2022 | US$941k | US$500k | -US$32m |
| Sep 30 2022 | n/a | n/a | -US$29m |
| Jun 30 2022 | n/a | n/a | -US$19m |
| Mar 31 2022 | n/a | n/a | -US$17m |
| Dec 31 2021 | US$677k | US$379k | -US$13m |
| Sep 30 2021 | n/a | n/a | -US$11m |
| Jun 30 2021 | n/a | n/a | -US$9m |
| Mar 31 2021 | n/a | n/a | -US$8m |
| Dec 31 2020 | US$1m | US$340k | -US$8m |
| Sep 30 2020 | n/a | n/a | -US$7m |
| Jun 30 2020 | n/a | n/a | -US$8m |
| Mar 31 2020 | n/a | n/a | -US$7m |
| Dec 31 2019 | US$518k | US$315k | -US$7m |
| Sep 30 2019 | n/a | n/a | -US$6m |
| Jun 30 2019 | n/a | n/a | -US$4m |
| Mar 31 2019 | n/a | n/a | -US$3m |
| Dec 31 2018 | US$275k | US$258k | -US$2m |
報酬と市場: Davidの 総報酬 ($USD 544.60K ) は、 US市場 ($USD 646.00K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Davidの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
David Arthur (61 yo)
5.3yrs
在職期間
US$544,600
報酬
Mr. David J. Arthur, M.B.A., has been President at Salarius Pharmaceuticals, Inc since July 19, 2019 and Chief Executive Officer & Director at Salarius Pharmaceuticals, Inc. since July 2019. Mr. Arthur ser...
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Director | 5.3yrs | US$544.60k | 0.43% $ 9.3k | |
| Independent Director | 4.4yrs | US$53.76k | 0.026% $ 559.5 | |
| Independent Director | 5.3yrs | US$45.26k | 0.012% $ 273.6 | |
| Independent Director | 5.3yrs | US$67.26k | 0.029% $ 626.3 | |
| Chairman of the Board | 5.3yrs | US$82.26k | 0.025% $ 542.6 | |
| Independent Director | 5.3yrs | US$64.76k | 0.024% $ 516.8 |
5.3yrs
平均在職期間
63yo
平均年齢
経験豊富なボード: SLRXの 取締役会 は 経験豊富 であると考えられます ( 5.3年の平均在任期間)。